Clarius Group LLC’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.1M Sell
10,267
-1,226
-11% -$132K 0.06% 135
2025
Q1
$1.16M Buy
11,493
+2,968
+35% +$299K 0.07% 129
2024
Q4
$761K Buy
8,525
+567
+7% +$50.6K 0.05% 149
2024
Q3
$664K Sell
7,958
-112
-1% -$9.35K 0.05% 173
2024
Q2
$621K Sell
8,070
-271
-3% -$20.9K 0.04% 186
2024
Q1
$571K Sell
8,341
-1,184
-12% -$81.1K 0.04% 201
2023
Q4
$551K Sell
9,525
-423
-4% -$24.5K 0.05% 219
2023
Q3
$525K Sell
9,948
-2,149
-18% -$113K 0.05% 208
2023
Q2
$654K Buy
12,097
+60
+0.5% +$3.25K 0.05% 207
2023
Q1
$602K Buy
12,037
+52
+0.4% +$2.6K 0.05% 215
2022
Q4
$555K Buy
11,985
+655
+6% +$30.3K 0.05% 229
2022
Q3
$439K Sell
11,330
-141
-1% -$5.46K 0.04% 244
2022
Q2
$428K Buy
11,471
+1,229
+12% +$45.9K 0.04% 246
2022
Q1
$435K Hold
10,242
0.03% 269
2021
Q4
$435K Buy
10,242
+169
+2% +$7.18K 0.03% 269
2021
Q3
$437K Buy
10,073
+769
+8% +$33.4K 0.04% 244
2021
Q2
$398K Buy
9,304
+335
+4% +$14.3K 0.04% 257
2021
Q1
$347K Buy
8,969
+260
+3% +$10.1K 0.03% 262
2020
Q4
$313K Sell
8,709
-692
-7% -$24.9K 0.03% 255
2020
Q3
$359K Buy
9,401
+50
+0.5% +$1.91K 0.05% 189
2020
Q2
$328K Buy
9,351
+356
+4% +$12.5K 0.05% 199
2020
Q1
$294K Buy
8,995
+951
+12% +$31.1K 0.06% 182
2019
Q4
$342K Sell
8,044
-1,136
-12% -$48.3K 0.05% 180
2019
Q3
$374K Buy
9,180
+2,357
+35% +$96K 0.07% 156
2019
Q2
$293K Sell
6,823
-1,046
-13% -$44.9K 0.06% 175
2019
Q1
$302K Buy
+7,869
New +$302K 0.07% 140